This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities
Experimental & Molecular Medicine Open Access 07 October 2022
-
Structural diversity of p63 and p73 isoforms
Cell Death & Differentiation Open Access 21 March 2022
-
Tissue-specific expression of p73 and p63 isoforms in human tissues
Cell Death & Disease Open Access 27 July 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C. p53 mutations in human cancer. Science 253, 49–53 (1991).
Kaghad, M. et al. Monoallelically expressed gene related to p53 at 1 p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90, 809–819 (1997).
Jost, A.C., Marin, C.M. & Kaelin, Jr., G.W. p73 is a human p53-related protein that can induce apoptosis. Nature 389, 191–194 (1997).
Schmale, H. & Bamberger, C. A novel protein with strong homology to the tumor suppressor p53. Oncogene 15, 1363–1367 (1997).
Li, L & et al. Identification of 3q21–22 deletions in urinary bladder carcinogenesis by superimposed histologic and genetic mapping. American Urologic Association Conference, An abstract (1998).
Bian, J.H. & Sun, Y. p53CP, a putative p53 competing protein that specifically binds to the consensus p53 DNA binding sitesCa third member of the p53 family. Proc. Natl. Acad. Sci. USA 94, 14753–14758 (1997).
Zeiner, M. & Gehrig, U. Cloning of 5′ cDNA regions by inverse PCR. Biotechniques 17, 1051–1053 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Trink, B., Okami, K., Wu, L. et al. A new human p53 homologue. Nat Med 4, 747–748 (1998). https://doi.org/10.1038/nm0798-747
Issue Date:
DOI: https://doi.org/10.1038/nm0798-747
This article is cited by
-
DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities
Experimental & Molecular Medicine (2022)
-
Structural diversity of p63 and p73 isoforms
Cell Death & Differentiation (2022)
-
Tissue-specific expression of p73 and p63 isoforms in human tissues
Cell Death & Disease (2021)
-
p53 switches off pluripotency on differentiation
Stem Cell Research & Therapy (2017)
-
Ccdc3: A New P63 Target Involved in Regulation Of Liver Lipid Metabolism
Scientific Reports (2017)